Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea
Helen Fifer, Usha Natarajan, Lucy C. Jones, Sarah Alexander, Gwenda Hughes, Daniel Golparian, Magnus Unemo
Abstract
Open-access reader
Helen Fifer, Usha Natarajan, Lucy C. Jones, Sarah Alexander, Gwenda Hughes, Daniel Golparian, Magnus Unemo
Abstract
Open-access reader
Increasing antibacterial resistance in Neisseria gonorrhoeae is threatening the success of routine treatment. This letter describes the clinical failure of ceftriaxone and azithromycin in a patient with gonorrhea.
OpenAlex reports 344 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Increasing antibacterial resistance in Neisseria gonorrhoeae is threatening the success of routine treatment. This letter describes the clinical failure of ceftriaxone and azithromycin in a patient with gonorrhea.
Key concepts: Medicine, Gonorrhea, Antimicrobial, Dual (grammatical number), Anti-Infective Agents, Intensive care medicine, Internal medicine, Microbiology